Fluconazole 150 mg: Clinical Trials

6 trials of Fluconazole 150 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 recruiting, 1 active not recruiting. 2 Phase 4, 1 Early Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Unknown 1
Early Phase 11Active not recruiting 1
Not applicable1Recruiting 1
Phase 21Unknown 1
Phase 31Unknown 1

Follow Fluconazole 150 mg: new trials by email Literature Review of Fluconazole 150 mg trials Research Report on Fluconazole 150 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis
Phase 4RecruitingUrooj Fatima1262025-11-012026-01-15
The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
Placebo, Fluconazole 150 mg - Cardiovascular
Not applicableRecruitingUniversité de Sherbrooke402025-11-012026-04-13
Endothelial Derived Hyperpolarization Factor and Vascular Control
Fluconazole 150 mg - Healthy
Phase 4UnknownUniversity of Oklahoma302022-02-192024-07-23
Vulvovaginal Candidiasis in Canadian Females
Fluconazole 150 mg, Boric Acid Supp,Vag - Candidiasis, Vulvovaginal
Early Phase 1Active not recruitingUniversity of Manitoba1202021-12-072026-05-06
SD-OCT Guided Treatment of Fungal Chorioretinitis
Fluconazole 150 mg - Fungal Retinitis
UnknownBenha University102020-01-152021-12-15
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis
Phase 2 / Phase 3UnknownProFem GmbH4322019-10-012022-09-22

Conditions studied

Candidiasis, Vulvovaginal (2)  ·  Chorioretinitis (1)  ·  Sedentary Behavior (1)  ·  Tinea (1)  ·  Vulvovaginitis (1)

Sponsors

Benha University (1)  ·  ProFem GmbH (1)  ·  University of Manitoba (1)  ·  University of Oklahoma (1)  ·  Université de Sherbrooke (1)  ·  Urooj Fatima (1)

Countries

Canada (2)  ·  Austria (1)  ·  Pakistan (1)  ·  Poland (1)  ·  Slovakia (1)  ·  United Arab Emirates (1)  ·  United States (1)

Top investigators

Aleeza Gerstein, PhD (1)  ·  Herbert Kiss, Prof. (1)  ·  Jeremy M Kellawan, PhD (1)  ·  Myles W O'Brien, PhD (1)  ·  Urooj Fatima, MBBS (1)

Results publications

PMID 41420405, PMID 41845293